Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan

被引:16
|
作者
Saghari, Mohsen [1 ]
Gholamrezanezhad, Ali [1 ]
Mirpour, Sahar [1 ]
Eftekhari, Mohammad [1 ]
Takavar, Abbas [1 ]
Fard-Esfahani, Armaghan [1 ]
Fallahi, Babak [1 ]
Beiki, Davood [1 ]
机构
[1] Univ Tehran, Res Inst Nucl Med, Tehran 14114, Iran
关键词
differentiated thyroid carcinoma; thyroglobulin; whole-body scanning;
D O I
10.1097/00006231-200607000-00004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction In the management of patients with differentiated thyroid carcinoma, serum thyroglobulin levels are often well correlated with whole-body radioiodine scanning (WBS) results. However, occasionally, a mismatched result - increased thyroglobulin with negative WBS - is observed. Radioiodine therapy has been suggested as a therapeutic choice with controversial results. Method We studied 32 differentiated thyroid carcinoma patients with elevated thyroglobulin level and negative WBS who had been treated with high-dose radioiodine. With a mean follow-up of 25.6 months (all follow-ups > 11 months), thyroglobulin and thyroid-stimulating hormone levels, WBS, clinical, radiographic and pathological findings following treatment were recorded. Results The mean pre-therapy off-treatment thyroglobulin was 152 +/- 119.0 ng (.) ml(-1). Although there was a mild trend towards an increase in thyroglobulin in the first post-treatment year, the difference was not significant. At the end of the follow-ups, 22 patients (68.7%) were categorized as non-responders to radioiodine therapy (any change or elevation of thyroglobulin or radiological and pathological evidences of progression), four patients (12.5%) as partial responders (transient reduction but not a normalization of thyroglobulin) and six patients (18.7%) as responders (normalization of thyroglobulin with no evidence of remnant disease). In nine of 10 partial and complete responders, reduction or normalization of thyroglobulin had occurred in the first post-treatment year. Conclusion We recommend that in differentiated thyroid carcinoma patients with elevated thyroglobulin and negative WBS, at least one course of radioiodine therapy should be undertaken and if reduction or normalization of serum thyroglobulin is not achieved, repeated courses of radioiodine therapy are not logical and other therapeutic methods should be applied.
引用
收藏
页码:567 / 572
页数:6
相关论文
共 50 条
  • [31] Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer
    Franzius, C.
    Dietlein, M.
    Biermann, M.
    Fruehwald, M.
    Linden, T.
    Busky, P.
    Reiners, C.
    Schober, O.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2007, 46 (05): : 224 - 231
  • [32] The impact of qualitative [18F]FDG PET/CT in predicting clinical outcomes of post-surgical differentiated thyroid cancer patients with elevated thyroglobulin and negative radioiodine whole-body scan
    Ha, Le Ngoc
    Thi, Phuong Nguyen
    Son, Mai Hong
    BMC SURGERY, 2024, 24 (01)
  • [33] Clinical Implications of Adding SPECT/CT to Radioiodine Whole-Body Scan in Patients With Differentiated Thyroid Cancer
    Chong, Ari
    Seo, Youngduk
    Bang, Ji-In
    Park, Sohyun
    Kim, Keunyoung
    Hong, Chae Moon
    Choi, Miyoung
    Oh, So Won
    Lee, Sang-Woo
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (03) : 215 - 225
  • [34] Usefulness of iodine-123 whole-body scan in planning iodine-131 treatment of the differentiated thyroid carcinoma in children and adolescence
    Villani, Maria F.
    Grossi, Armando
    Cassano, Bartolomeo
    Pizzoferro, Milena
    Ubertini, Graziamaria
    Longo, Mariaconcetta
    Garganese, Maria C.
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1121 - 1128
  • [35] Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma
    Salvatori, M
    Saletnich, I
    Rufini, V
    Troncone, L
    CLINICAL NUCLEAR MEDICINE, 1997, 22 (06) : 380 - 384
  • [36] Iodine-131 whole-body scintigraphy differentiated thyroid carcinoma
    Verburg, Frederik A.
    Gruenwald, Frank
    Lassmann, Michael
    Haenscheid, Heribert
    Luster, Markus
    Dietlein, Markus
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2018, 57 (04): : 124 - 136
  • [37] Role of F-18 FDG PET/CT in elevated thyroglobulin and negative diagnostic whole body iodine-131 scan in patients with differentiated thyroid cancer
    Mittal, B. R.
    Kashyap, R.
    Bhattacharya, A.
    Singh, B.
    Sood, A.
    Shukla, J.
    Dutta, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S449 - S449
  • [38] Radioiodine whole body scan pitfalls in differentiated thyroid cancer
    Basso, Cristina
    Colapinto, Alessandra
    Vicennati, Valentina
    Gambineri, Alessandra
    Pelusi, Carla
    Di Dalmazi, Guido
    Rizzini, Elisa Lodi
    Tabacchi, Elena
    Golemi, Arber
    Calderoni, Letizia
    Fanti, Stefano
    Pagotto, Uberto
    Repaci, Andrea
    ENDOCRINE, 2024, 85 (02) : 493 - 508
  • [39] Diagnostic accuracy of 18-F-FDG PET/CT and its relationship with thyroglobulin levels in Differentiated Thyroid Carcinoma (DTC) with Evidence of Disease and Negative Radioiodine Whole-Body Scan
    Garcia-Burillo, A.
    Mariscal, E.
    Kisiel, N.
    Barios, M.
    Obiols, G.
    Castell, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S348 - S348
  • [40] The Case for Obtaining a Diagnostic Whole-Body Scan Prior to Iodine 131 Treatment of Differentiated Thyroid Cancer
    McDougall, I. Ross
    THYROID, 2009, 19 (08) : 811 - 813